A K Hemanth Kumar1, V Chandrasekaran1, T Kannan1, A Lakshmi Murali2, J Lavanya3, V Sudha1, Soumya Swaminathan1, Geetha Ramachandran4. 1. Department of Biochemistry and Clinical Pharmacology, National Institute for Research in Tuberculosis, Mayor Sathyamoorthy Road, Chetpet, Chennai, 600 031, India. 2. State TB Officer, Chennai, Tamil Nadu, India. 3. District TB Officer, Chennai, India. 4. Department of Biochemistry and Clinical Pharmacology, National Institute for Research in Tuberculosis, Mayor Sathyamoorthy Road, Chetpet, Chennai, 600 031, India. geethar@nirt.res.in.
Abstract
PURPOSE: The aim of the study was to compare plasma concentrations of rifampicin (RMP), isoniazid (INH) and pyrazinamide (PZA) between tuberculosis (TB) patients with and without diabetes mellitus (DM). METHODS: Two-hour post-dosing concentrations of RMP, INH and PZA were determined in adult TB patients that were studied with (n = 452) and without DM (n = 1460), treated with a thrice-weekly regimen in India. Drug concentrations were estimated by HPLC. RESULTS: The median (IQR) INH [6.6 (3.9-10.0) and 7.8 (4.6-11.3)] and PZA [31.0 (22.3-38.0) and 34.1 (24.6-42.7)] microgram per milliliter concentrations were significantly lower in diabetic than non-diabetic TB patients (p < 0.001 for both drugs). Blood glucose was negatively correlated with plasma INH (r = -0.09, p < 0.001) and PZA (r = -0.092, p < 0.001). Multiple linear regression analysis showed RMP, INH and PZA concentrations were influenced by age and drug doses, INH and PZA by DM, RMP by alcohol use and PZA by gender and category of ATT. DM reduced INH and PZA concentrations by 0.8 and 3.0 μg/ml, respectively. CONCLUSIONS: TB patients with DM had lower INH and PZA concentrations. Negative correlation between blood glucose and drug concentrations suggests delayed absorption/faster elimination of INH and PZA in the presence of elevated glucose.
PURPOSE: The aim of the study was to compare plasma concentrations of rifampicin (RMP), isoniazid (INH) and pyrazinamide (PZA) between tuberculosis (TB) patients with and without diabetes mellitus (DM). METHODS: Two-hour post-dosing concentrations of RMP, INH and PZA were determined in adult TB patients that were studied with (n = 452) and without DM (n = 1460), treated with a thrice-weekly regimen in India. Drug concentrations were estimated by HPLC. RESULTS: The median (IQR) INH [6.6 (3.9-10.0) and 7.8 (4.6-11.3)] and PZA [31.0 (22.3-38.0) and 34.1 (24.6-42.7)] microgram per milliliter concentrations were significantly lower in diabetic than non-diabetic TBpatients (p < 0.001 for both drugs). Blood glucose was negatively correlated with plasma INH (r = -0.09, p < 0.001) and PZA (r = -0.092, p < 0.001). Multiple linear regression analysis showed RMP, INH and PZA concentrations were influenced by age and drug doses, INH and PZA by DM, RMP by alcohol use and PZA by gender and category of ATT. DM reduced INH and PZA concentrations by 0.8 and 3.0 μg/ml, respectively. CONCLUSIONS: TB patients with DM had lower INH and PZA concentrations. Negative correlation between blood glucose and drug concentrations suggests delayed absorption/faster elimination of INH and PZA in the presence of elevated glucose.
Entities:
Keywords:
Anti-tuberculosis drug concentrations; Diabetes mellitus; Revised National Tuberculosis Control Programme; Tuberculosis
Authors: Hanneke M J Nijland; Rovina Ruslami; Janneke E Stalenhoef; Erni J Nelwan; Bachti Alisjahbana; Ron H H Nelwan; Andre J A M van der Ven; Halim Danusantoso; Rob E Aarnoutse; Reinout van Crevel Journal: Clin Infect Dis Date: 2006-08-22 Impact factor: 9.079
Authors: Min Jung Chang; Jung-Woo Chae; Hwi-Yeol Yun; Jangik I Lee; Hye Duck Choi; Jihye Kim; Jong Sun Park; Young-Jae Cho; Ho Il Yoon; Choon-Taek Lee; Wan Gyoon Shin; Jae-Ho Lee Journal: Tuberculosis (Edinb) Date: 2014-11-15 Impact factor: 3.131
Authors: Susan P Fisher-Hoch; Erin Whitney; Joseph B McCormick; Gonzalo Crespo; Brian Smith; Mohammad H Rahbar; Blanca I Restrepo Journal: Scand J Infect Dis Date: 2008
Authors: A K Hemanth Kumar; T Kannan; V Chandrasekaran; V Sudha; A Vijayakumar; K Ramesh; J Lavanya; S Swaminathan; G Ramachandran Journal: Int J Tuberc Lung Dis Date: 2016-09 Impact factor: 2.373
Authors: Rovina Ruslami; Hanneke M J Nijland; I Gusti N Adhiarta; Sri H K S Kariadi; Bachti Alisjahbana; Rob E Aarnoutse; Reinout van Crevel Journal: Antimicrob Agents Chemother Date: 2009-12-28 Impact factor: 5.191
Authors: Yuri F van der Heijden; Fareed Abdullah; Bruno B Andrade; Jason R Andrews; Devasahayam J Christopher; Julio Croda; Heather Ewing; David W Haas; Mark Hatherill; C Robert Horsburgh; Vidya Mave; Helder I Nakaya; Valeria Rolla; Sudha Srinivasan; Retna Indah Sugiyono; Cesar Ugarte-Gil; Carol Hamilton Journal: Tuberculosis (Edinb) Date: 2018-10-01 Impact factor: 3.131
Authors: Quinn Dufurrena; Farhad M Amjad; Philipp E Scherer; Louis M Weiss; Jyothi Nagajyothi; Jesse Roth; Herbert B Tanowitz; Regina Kuliawat Journal: Parasitol Res Date: 2016-12-24 Impact factor: 2.289